Sites of Synchronous Distant Metastases, Prognosis, and Nomogram for Small Cell Lung Cancer Patients with Bone Metastasis: A Large Cohort Retrospective Study

Table 3

OS rates (median, mean) of SCLC patients with BM in different metastatic sites.

Metastatic sites	Median survival (months)	Mean survival (months)
Bone-only	7.00 ± 0.25	9.30 ± 0.31
Bone and brain	5.00 ± 0.52	7.12 ± 0.40
Bone and liver	5.00 ± 0.20	6.45 ± 0.20
Bone and lung	6.00 ± 0.53	7.63 ± 0.49
Bone, liver, and brain	5.00 ± 0.45	5.77 ± 0.29
Bone, lung, and brain	5.00 ± 1.04	6.69 ± 0.74
Bone, lung, and liver	4.00 ± 0.39	5.34 ± 0.24
Bone, lung, liver, and brain	3.00 ± 0.44	4.86 ± 0.33

OS, overall survival; SCLC, small cell lung cancer; BM, bone metastasis.